精神疾病中的脑成像与认知缺陷
Brain Imaging and Cognitive Deficits in Psychiatric Disorders.
作者信息
Ding Yudan, Guo Wenbin
机构信息
Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
出版信息
Biomedicines. 2024 Dec 18;12(12):2888. doi: 10.3390/biomedicines12122888.
Abstract
Over the last three decades, various neuroimaging techniques, such as magnetic resonance imaging (MRI), functional MRI, and positron emission tomography (PET), have played an essential role in improving our understanding of the pathogenesis of neuropsychiatric disorders [...].
摘要
在过去三十年中，各种神经成像技术，如磁共振成像（MRI）、功能磁共振成像和正电子发射断层扫描（PET），在增进我们对神经精神疾病发病机制的理解方面发挥了重要作用[...]。
相似文献
1
Brain Imaging and Cognitive Deficits in Psychiatric Disorders.精神疾病中的脑成像与认知缺陷
Biomedicines. 2024 Dec 18;12(12):2888. doi: 10.3390/biomedicines12122888.
2
The use of positron emission tomography/magnetic resonance imaging in dementia: A literature review.正电子发射断层扫描/磁共振成像在痴呆中的应用：文献综述。
Int J Geriatr Psychiatry. 2021 Oct;36(10):1501-1513. doi: 10.1002/gps.5586. Epub 2021 Jun 12.
3
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.用于评估心肌活力的正电子发射断层扫描：基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(16):1-80. Epub 2010 Jul 1.
4
Clinical neuroimaging in psychiatry.精神病学中的临床神经影像学
Harv Rev Psychiatry. 1995 Mar-Apr;2(6):297-312. doi: 10.3109/10673229509017151.
5
Future Prospects of Positron Emission Tomography-Magnetic Resonance Imaging Hybrid Systems and Applications in Psychiatric Disorders.正电子发射断层扫描-磁共振成像混合系统的未来前景及其在精神疾病中的应用
Pharmaceuticals (Basel). 2022 May 8;15(5):583. doi: 10.3390/ph15050583.
6
Hybrid PET-MRI Applications in Movement Disorders.混合 PET-MRI 在运动障碍中的应用。
Int Rev Neurobiol. 2019;144:211-257. doi: 10.1016/bs.irn.2018.10.003. Epub 2018 Nov 8.
7
Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.神经影像学及其他方法评估唐氏综合征患者的阿尔茨海默病。
Neuroimage Clin. 2017 Nov 6;17:263-271. doi: 10.1016/j.nicl.2017.10.022. eCollection 2018.
8
The Advents of Hybrid Imaging Modalities: A New Era in Neuroimaging Applications.混合成像模态的出现：神经成像应用的新时代。
Adv Biosyst. 2017 Aug;1(8):e1700019. doi: 10.1002/adbi.201700019. Epub 2017 Jun 27.
9
[Background and findings of neuroimaging in schizophrenia: an update].[精神分裂症神经影像学的背景与研究发现：最新进展]
Rev Neurol. 2011 Jan 1;52(1):27-36.
10
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.Tau 正电子发射断层扫描作为临床前和前驱期阿尔茨海默病预后标志物的准确性：与淀粉样蛋白正电子发射断层扫描和磁共振成像的头对头比较。
JAMA Neurol. 2021 Aug 1;78(8):961-971. doi: 10.1001/jamaneurol.2021.1858.
本文引用的文献
1
Functional Connectivity of Language-Related Cerebellar Regions Is Reduced in Schizophrenia Patients.精神分裂症患者语言相关小脑区域的功能连接性降低。
Biomedicines. 2024 Feb 21;12(3):480. doi: 10.3390/biomedicines12030480.
2
Genes Associated with Altered Brain Structure and Function in Obstructive Sleep Apnea.与阻塞性睡眠呼吸暂停中大脑结构和功能改变相关的基因
Biomedicines. 2023 Dec 20;12(1):15. doi: 10.3390/biomedicines12010015.
3
Integrative omics analysis reveals epigenomic and transcriptomic signatures underlying brain structural deficits in major depressive disorder.整合组学分析揭示了重度抑郁症患者大脑结构缺陷的表观基因组和转录组特征。
Transl Psychiatry. 2024 Jan 9;14(1):17. doi: 10.1038/s41398-023-02724-8.
4
Breaking the Fear Barrier: Aberrant Activity of Fear Networks as a Prognostic Biomarker in Patients with Panic Disorder Normalized by Pharmacotherapy.突破恐惧障碍：惊恐障碍患者恐惧网络的异常活动作为一种经药物治疗后恢复正常的预后生物标志物。
Biomedicines. 2023 Aug 29;11(9):2420. doi: 10.3390/biomedicines11092420.
5
Sleep Traits Causally Affect the Brain Cortical Structure: A Mendelian Randomization Study.睡眠特征对大脑皮质结构有因果影响：一项孟德尔随机化研究。
Biomedicines. 2023 Aug 18;11(8):2296. doi: 10.3390/biomedicines11082296.
6
Hypoactive Visual Cortex, Prefrontal Cortex and Insula during Self-Face Recognition in Adults with First-Episode Major Depressive Disorder.首发重度抑郁症成年患者自我面孔识别过程中视觉皮层、前额叶皮层和脑岛的活动减退
Biomedicines. 2023 Aug 4;11(8):2200. doi: 10.3390/biomedicines11082200.
7
Candidate biomarkers in psychiatric disorders: state of the field.精神疾病中的候选生物标志物：该领域的现状。
World Psychiatry. 2023 Jun;22(2):236-262. doi: 10.1002/wps.21078.
8
Metabolomic Biomarkers in Anxiety Disorders.焦虑障碍的代谢组学生物标志物。
Int J Mol Sci. 2020 Jul 6;21(13):4784. doi: 10.3390/ijms21134784.
9
Systematic review of blood transcriptome profiling in neuropsychiatric disorders: guidelines for biomarker discovery.神经精神疾病血液转录组分析的系统评价：生物标志物发现指南
Hum Psychopharmacol. 2016 Sep;31(5):373-81. doi: 10.1002/hup.2546.
10
Looking for a "biological test" to diagnose"schizophrenia": are we chasing red herrings?寻找用于诊断“精神分裂症”的“生物学检测”：我们是在捕风捉影吗？
World Psychiatry. 2011 Feb;10(1):32. doi: 10.1002/j.2051-5545.2011.tb00005.x.
Zotero 插件